Investor Relations (IR) Questions: Acasti Pharma ACST
Click here to return to the biotech IRQ Index
Answers received: January 2013
1) When is the last time ACST raised cash through an offering (diluted)?
Sept 2011, $8M and Feb 2012, $2M are our last 2 offering
2) How much cash (not cash equivalents) does ACST have?
4.5M$ in cash and short term investments
3) What and approximately when is the next known catalyst?
Phase II open label results, H1 2013
4) What is ACST's quarterly cash burn?
We have sufficient cash to complete our ongoing clinical work, (app cash burn of 1M)
5) Does ACST have an existing line of credit and if so how much can they draw against it?
We do not currently have a line of credit
1) When is the last time ACST raised cash through an offering (diluted)?
Sept 2011, $8M and Feb 2012, $2M are our last 2 offering
2) How much cash (not cash equivalents) does ACST have?
4.5M$ in cash and short term investments
3) What and approximately when is the next known catalyst?
Phase II open label results, H1 2013
4) What is ACST's quarterly cash burn?
We have sufficient cash to complete our ongoing clinical work, (app cash burn of 1M)
5) Does ACST have an existing line of credit and if so how much can they draw against it?
We do not currently have a line of credit